Antachopoulos Charalampos, Papakonstantinou Eugenia, Dotis John, Bibashi Evangelia, Tamiolaki Maria, Koliouskas Dimitrios, Roilides Emmanuel
Third Department of Pediatrics, Aristotle University, Hippokration Hospital, Thessaloniki, Greece.
J Pediatr Hematol Oncol. 2005 May;27(5):283-5. doi: 10.1097/01.mph.0000164865.70522.d7.
Disseminated Trichosporon infection in neutropenic patients carries a poor prognosis. Clinical evidence on the use of voriconazole for this infection is limited. The authors report a case of Trichosporon asahii fungemia refractory to liposomal amphotericin B treatment in a boy with acute lymphoblastic leukemia, which resolved after the addition of voriconazole. Both voriconazole and amphotericin B exhibited low minimal inhibitory concentrations and minimal fungicidal concentrations, and their combination was indifferent in vitro. The use of voriconazole for the treatment of trichosporonosis in patients with hematologic malignancies deserves further study.
中性粒细胞减少患者的播散性毛孢子菌感染预后较差。关于伏立康唑用于治疗这种感染的临床证据有限。作者报告了1例急性淋巴细胞白血病男孩,其感染嗜麦芽窄食单胞菌性真菌血症,对脂质体两性霉素B治疗无效,在加用伏立康唑后病情得到缓解。伏立康唑和两性霉素B均表现出较低的最低抑菌浓度和最低杀菌浓度,二者联合在体外无协同作用。伏立康唑用于治疗血液系统恶性肿瘤患者的毛孢子菌病值得进一步研究。